{
    "title": "Oxford to study anti-inflammatory drug Humira as potential COVID-19 treatment",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8789119/Oxford-study-anti-inflammatory-drug-Humira-potential-COVID-19-treatment.html",
    "date": "2020-09-30",
    "keywords": [
        "covid19",
        "humira",
        "oxford",
        "care",
        "josephine",
        "mason",
        "kelland",
        "london",
        "university",
        "medicine",
        "drug",
        "disease",
        "arthritis",
        "trial",
        "community",
        "system",
        "wednesday",
        "prescription",
        "adalimumab",
        "treatment",
        "effort",
        "coronavirus",
        "brand",
        "name",
        "abbvie",
        "type",
        "antitumor",
        "necrosis",
        "factor",
        "inflammatory",
        "bowel",
        "statement",
        "avidcc",
        "britain",
        "range",
        "rheumatoid",
        "crohns",
        "colitis",
        "psoriasis",
        "availability",
        "novartis",
        "research",
        "remdesivir",
        "dexamethasone",
        "antiinflammatory",
        "overreaction",
        "cytokine",
        "storm",
        "role",
        "escalation",
        "hit",
        "wave",
        "uk",
        "time",
        "study",
        "initiative",
        "health",
        "charity",
        "wellcome",
        "bill",
        "melinda",
        "foundation",
        "mastercard",
        "reporting",
        "kate",
        "john",
        "miller",
        "editing",
        "mark",
        "heinrich"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}